Fang Cai
- LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthmaBy Fang Cai, David F. Choy, Jochen Brumm, Cecile Holweg, Alyssa Morimoto, Joseph R. Arron, John Matthews and Heleen ScheerensFang Cai1ITGR/OMNI Biomarker Development, Genentech Inc., South San Francisco, CA United StatesDavid F. Choy2ITGR Diagnostic Discovery, Genentech Inc., South San Francisco, CA United StatesJochen Brumm3Biostatistics, Genentech Inc., South San Francisco, CA United StatesCecile Holweg1ITGR/OMNI Biomarker Development, Genentech Inc., South San Francisco, CA United StatesAlyssa Morimoto1ITGR/OMNI Biomarker Development, Genentech Inc., South San Francisco, CA United StatesJoseph R. Arron4Immunology Research, Genentech Inc., South San Francisco, CA United StatesJohn Matthews5Immunology Product Development, Genentech Inc., South San Francisco, CA United StatesHeleen Scheerens1ITGR/OMNI Biomarker Development, Genentech Inc., South San Francisco, CA United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.